siRNA-targeted COL8A1 inhibits proliferation, reduces invasion and enhances sensitivity to D-limonence treatment in hepatocarcinoma cells.

Source:http://linkedlifedata.com/resource/pubmed/id/19109829

Download in:

View as

General Info

PMID
19109829